BioSpace News Archive

ROBOSENSE NAMED CES 2019 INNOVATION AWARDS HONOREE FOR SAFER AUTONOMOUS CAR TECHNOLOGY WITH “GAZE” FUNCTION SIMILAR TO HUMAN EYES

Revolutionary RoboSense RS-IPLS Intelligent Perception LiDAR System is the First Hardware & Software Algorithm Based Solution Created for the Mass Production of Safer Autonomous Vehicles

November 20, 2018
·
7 min read
Business

AP-HP, Greater Paris University Hospitals and TRIBVN Healthcare partner to co-develop a National Telepathology Platform

During the annual congress of the French Society of Pathology which is held held from 5th to 8th November 2018 in Paris, AP-HP, Greater Paris University Hospitals and TRIBVN Healthcare are pleased to announce a 5-year strategic partnership to develop and operate a National Telepathology Platform.

November 20, 2018
·
2 min read
NORTHSEA THERAPEUTICS: Icosabutate latest data shows direct and potent anti-fibrotic effect in both differentiated rodent NASH models and human stellate cells

Results to be presented at the AASLD congress 2018, 9-13 November

November 20, 2018
·
6 min read
Drug Development

TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting

Initial data from AMBER trial of TSR-022 (anti-TIM-3) in combination with TSR-042 (anti-PD-1) demonstrated clinical activity in patients who have progressed following anti-PD-1 treatment

November 20, 2018
·
10 min read
Business

Intravacc and BCHT enter into license agreement for production of a Hib conjugate vaccine

Intravacc and Changchun BCHT Biotechnology Co today announced that they have entered into a non-exclusive license agreement towards the development ofa Haemophilus influenzae Type B (Hib) Conjugate Vaccine within the People’s Republic of China.

November 20, 2018
·
2 min read
Biotech Bay

Ultragenyx to Present at Upcoming November 2018 Investor Conferences

Ultragenyx Pharmaceutical Inc. today announced that it will present at the following upcoming investor conferences

November 20, 2018
·
1 min read
Policy

Yoga declared “most popular complementary health approach” in US by Centers for Disease Control

“Yoga is the most popular complementary health approach in the United States - used by 14.3% of the adult population, or 35.2 million people”, according to a statement published on Centers for Disease Control and Prevention (CDC) website on November eight quoting National Health Interview Survey (NHIS).

November 20, 2018
·
2 min read
Policy

AAFA Statement on FDA Approval of Primatene Mist for Mild Asthma

People with asthma have more treatment choices than ever before and the FDA recently announced approval for the readmittance of Primatene Mist – an over-the-counter epinephrine inhaler.

November 20, 2018
·
2 min read
FDA

Theravance Biopharma and Mylan Receive FDA Approval for YUPELRITM (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease

YUPELRI (revefenacin) is the first and only once-daily, nebulized bronchodilator approved for the treatment of COPD in the US

November 20, 2018
·
10 min read
BioArctic is awarded grant from EU’s Horizon 2020 for participation in research consortium for better diagnostic tools and biomarkers for Parkinson’s

BioArctic AB has been awarded a grant from EU’s research and innovation program Horizon 2020.

November 20, 2018
·
5 min read